Medindia LOGIN REGISTER
Medindia
Advertisement

US Hemostasis Diagnostics Market 2021: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Thursday, November 23, 2017 Research News
Advertisement
LONDON, Nov. 22, 2017 /PRNewswire/ --
Advertisement

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Advertisement

Download the full report: https://www.reportbuyer.com/product/3963911

Summary

This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the next five years.

The report explores business and technological trends in the US coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Coagulation Tests

Activated Clotting Time (ACT) (1), Activated Protein C Resistance,Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII,  Factor IX,Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand’s Factor Fav/Ag, and others.

Sales and Market Share Analysis

- Sales and market shares of major instrument and reagent suppliers.

Competitive Assessments

- Extensive strategic profiles ofmajor suppliers and emerging market entrants.

Market Segmentation Analysis

- Comprehensive marketsegmentation analysis, including:

   - Hospitals   - Commercial/Private Laboratories   - Physician Offices

- Test volume forecasts for over 40 major proceduresby market segment.

Current and Emerging Products

- Review of established and emerging procedures.

- Comparison of automated and semi-automatedanalyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.

Technology Review

- Analysis of current and emerging technologies and their potential market applications.

- Comprehensive lists of companies developingor marketing new technologies and products by test.

Strategic Recommendations

- Product development and business expansion opportunities with significant market appeal.

- "Ideal" product models with tentativeprices and operating characteristics.

- Alternative market penetrationstrategies for instrument and reagent suppliers.

- Potential market entry barriers and risks.

Contains 424 pages and 37 tables

Download the full report: https://www.reportbuyer.com/product/3963911 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com

 

View original content:http://www.prnewswire.com/news-releases/us-hemostasis-diagnostics-market-2021-emerging-opportunities-and-growth-strategies-for-instrument-and-reagent-suppliers-300561260.html

SOURCE ReportBuyer

Sponsored Post and Backlink Submission


Latest Press Release on Research News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close